Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q3 FY26 results · Oct–Dec 2025
Unichem Laboratories reported revenue from operations of ₹521.17 crore (down 2.2% from Q3 FY25) and net profit of ₹264.29 crore (up 356.9% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 521.17 | 533.09 | −2.2% | 578.96 | −10.0% |
| Other income | 11.80 | 13.62 | −13.4% | 20.97 | −43.7% |
| Total income | 532.97 | 546.71 | −2.5% | 599.93 | −11.2% |
| Profit before tax | 293.43 | 61.85 | +374.4% | (10.82) | Turned profit |
| Net profit for the period | 264.29 | 57.85 | +356.9% | (11.89) | Turned profit |
| EPS, basic (₹) | 37.54 | 8.22 | +356.7% | (1.69) | Turned profit |
| Net margin (%) | 50.7 | 10.9 | -2.1 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 314.90 | 447.83 | −29.7% | 356.90 | −11.8% |
| Other income | 15.03 | 18.93 | −20.6% | 21.40 | −29.8% |
| Total income | 329.93 | 466.76 | −29.3% | 378.30 | −12.8% |
| Profit before tax | 259.82 | 61.80 | +320.4% | (37.83) | Turned profit |
| Net profit for the period | 216.11 | 46.89 | +360.9% | (39.93) | Turned profit |
| EPS, basic (₹) | 30.69 | 6.66 | +360.8% | (5.67) | Turned profit |
| Net margin (%) | 68.6 | 10.5 | -11.2 |
Consolidated
- Filed with BSE
- 05 Feb 2026, 16:21 IST
- Board meeting
- 05 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 05 Feb 2026, 16:21 IST
- Board meeting
- 05 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE